Company intelligence / Profile preview
High Point Pharmaceuticals LLC
High Point, North Carolina, United Statesvtvtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
High Point Pharmaceuticals LLC was a pharmaceutical company founded in High Point, North Carolina in 2008 and is now out of business[1]. It had at least one patented small molecule (substituted aminothiazole derivative) and conducted a Phase 1 clinical trial (NCT01636245) evaluating HPP404 for weight loss in overweight or obese subjects[5][7]. No recent clinical results or advanced pipeline information is publicly available.
- Therapeutic areas
- Metabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on High Point Pharmaceuticals LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High Point Pharmaceuticals LLC.